CompletedPhase 4

Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years

France108 participantsStarted 2005-07

Plain-language summary

The aim of this trial is to lower the morbidity rate in elderly patients affected with systemic necrotizing vasculitides, by reducing mortality and improving global outcome.

Who can participate

Age range65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Newly diagnosed WG, MPA, PAN without HBV infection, or CSS * Patients can be still be enrolled within 1 month after starting corticosteroids if prescribed according to protocol. * within or after the 65th of anniversary * Age ≥ 65 years Exclusion Criteria: * Any cytotoxic drug within previous year * Co-existence of another systemic autoimmune disease, e.g., SLE, RA * Virus-associated vasculitides * HIV positivity * Malignancy (usually excluded unless approved by the trial coordinator) * Age \< 65 years * Inability to give informed consent

What they're measuring

Number of side effects (morbidity)

Timeframe: at 3 years

Trial details

NCT IDNCT00307671

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2011-07

View on ClinicalTrials.gov More Vasculitis trials